Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04895332

BPOI (Berlin Pediatric Oxygenation Index) - A New Predictor for Imminent Failure of HFNC in Children Avoiding Delayed NIV or Intubation

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Charite University, Berlin, Germany · Academic / Other
Sex
All
Age
28 Days – 17 Years
Healthy volunteers
Not accepted

Summary

The investigators developed an index that integrates different flow-settings in High-flow nasal cannula (HFNC) therapy with non-invasively measured clinical parameters of oxygenation in pediatric patients. This observational study is designed to evaluate this index and to determine a cut-off value for imminent HFNC failure.

Detailed description

High-flow nasal cannula therapy is a broadly used instrument of respiratory support in pediatric and adult patients with respiratory failure. For adult patients with pneumonia and respiratory failure, there is a validated index (ROX; ratio SpO2/FiO2) which helps to identify those at risks for the need of intubation. This index however is not applicable in the pediatric population because the physiological values of respiratory rate vary greatly across different ages. Thus, based on the particularities of pediatric patients the investigators developed an index that integrates different flow-settings in HFNC therapy with non-invasively measured clinical parameters of oxygenation. The BPOI is defined as the ratio of the product of the peripherally measured oxygen saturation and the patient's body weight divided by the product of HFNC flow and the fraction of inspired oxygen: BPOI = (SpO2 \* kg) / (Flow \* FiO2)

Conditions

Timeline

Start date
2021-06-21
Primary completion
2021-12-31
Completion
2021-12-31
First posted
2021-05-20
Last updated
2024-01-18

Source: ClinicalTrials.gov record NCT04895332. Inclusion in this directory is not an endorsement.